UK approves Pfizer/BioNTech Covid-19 jab for use in 12 to 15-year-olds

The Pfizer Covid-19 jab was the first to be authorised for use in the UK at the end of last year.

The Pfizer/BioNTech Covid-19 vaccine approved for use for 12 to 15-year-olds (Nick Potts/PA)

The UK has approved the Pfizer/BioNTech coronavirus vaccine for use in children aged 12 to 15.

The Medicines and Healthcare products Regulatory Agency (MHRA) authorised the use of the jab in the younger age group on Friday following a review of its safety, quality and effectiveness.